Home›Research›Compare›CGRP vs KPV
Peptide ComparisonCGRP vs KPV
Both are Tissue Repair peptides.
CGRP
Calcitonin Gene-Related Peptide
Half-life: ~3.6 min / ~13.6 min (biphasic; sheep)
2 providers listed
KPV
Lys-Pro-Val
Half-life: Short (minutes to hours)
105 providers listed
CGRP carries stronger published evidence (RCT, 10 key studies) than KPV (Review, 3); both are research compounds.
CGRP
Half-life
~3.6 min / ~13.6 min (biphasic; sheep)
KPV
Half-life
Short (minutes to hours)
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | CGRP |
| Oral administration option | KPV |
| More provider options (2 vs 105) | KPV |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
CGRP
KPV
CGRP
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous prevent…
A Controlled Trial of Erenumab for Episodic Migraine
Three-year real-world effectiveness, treatment persistence, and planned discontinuation of anti-calcitonin ge…
Functional role of Nav1.8 channels in action potentials of mouse CGRP-lineage dorsal root ganglion neurons.
+6 more
KPV
Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Allev…
PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
About CGRP
Binds CLR/RAMP1 receptor complex. Causes vasodilation via cAMP/PKA/nitric oxide pathway. Modulates nociceptive signaling in the trigeminal system. Promotes bone healing and has anti-inflammatory effects in peripheral tissues.
About KPV
Derived from alpha-MSH; binds melanocortin receptors MC1R/MC3R to suppress NF-κB and inflammatory cytokines
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
CGRP
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Under clinical review
Being verified by our medical team before we display monitoring guidance for this peptide.
KPV
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Tissue Repair Comparisons
Browse all peptides →Educational research tools — not medical advice.